Hugh Jarrett

A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial

Andrew W. Bradbury, Catherine A Moakes, Matthew Popplewell et al. · The Lancet · 2023 · 392 citations · Full text

Medicine, Surgery, Vascular Surgery +14

Photobiomodulation with Near Infrared Light Helmet in a Pilot, Placebo Controlled Clinical Trial in Dementia Patients Testing Memory and Cognition

Marvin H. Berman, James P. Halper, Trent W Nichols et al. · Journal of Neurology and Neuroscience · 2017 · 171 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Bypass versus angio plasty in severe ischaemia of the leg - 2 (BASIL-2) trial: study protocol for a randomised controlled trial

Matthew Popplewell, Huw Davies, Hugh Jarrett et al. · Trials · 2016 · 154 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +15

BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial

Benjamin Hunt, Matthew Popplewell, Huw Davies et al. · Trials · 2017 · 74 citations · Full text

Medicine, Pharmacoeconomics, Surgery +16

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

David Ferry, Lucinda Billingham, Hugh Jarrett et al. · European Journal of Cancer · 2017 · 20 citations · Full text

Medicine, Oncology, Pharmacology +12